Javaid Mehwish, Ashrawi Dana, Landgren Rachel, Stevens Lori, Bello Rosalind, Foxhall Lewis, Mims Melissa, Ramondetta Lois
Office of Health Policy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
J Community Health. 2017 Feb;42(1):58-65. doi: 10.1007/s10900-016-0228-0.
The purpose of this study was to identify barriers to and facilitators of human papillomavirus (HPV) vaccination in children aged 9-17 years across Texas. A literature review informed the development of a web-based survey designed for people whose work involves HPV vaccination in settings serving pediatric patients. The survey was used to examine current HPV vaccine recommendation practices among healthcare providers, barriers to HPV vaccination, reasons for parent/caregiver vaccine refusal, staff and family education practices, utilization of reminder and recall systems and status of vaccine administration (payment, ordering and stocking). 1132 responses were received representing healthcare providers, administrative and managerial staff. Respondents identified perceived barriers to HPV vaccination as parental beliefs about lack of necessity of vaccination prior to sexual debut, parental concerns regarding safety and/or side effects, parental perceptions that their child is at low risk for HPV-related disease, and parental lack of knowledge that the vaccine is a series of three shots. Of responding healthcare providers, 94 % (n = 582) reported they recommend the vaccine for 9-12 year olds; however, same-day acceptance of the vaccine is low with only 5 % (n = 31) of providers reporting the HPV vaccine is "always" accepted the same day the recommendation is made. Healthcare providers and multidisciplinary care teams in pediatric care settings must work to identify gaps between recommendation and uptake to maximize clinical opportunities. Training in methods to communicate an effective HPV recommendation and patient education tailored to address identified barriers may be helpful to reduce missed opportunities and increase on-time HPV vaccinations.
本研究的目的是确定德克萨斯州9至17岁儿童人乳头瘤病毒(HPV)疫苗接种的障碍和促进因素。通过文献综述,为在儿科患者服务机构中从事HPV疫苗接种工作的人员设计了一项基于网络的调查。该调查用于检查医疗保健提供者当前的HPV疫苗推荐做法、HPV疫苗接种的障碍、家长/照顾者拒绝接种疫苗的原因、工作人员和家庭的教育做法、提醒和召回系统的使用情况以及疫苗接种的状况(支付、订购和库存)。共收到1132份回复,代表医疗保健提供者、行政和管理人员。受访者认为HPV疫苗接种的障碍包括:父母认为在首次性行为之前没有必要接种疫苗、父母对安全性和/或副作用的担忧、父母认为其孩子感染HPV相关疾病的风险较低,以及父母不知道该疫苗需要接种三针。在回复的医疗保健提供者中,94%(n = 582)报告他们为9至12岁的儿童推荐该疫苗;然而,当日接种率较低,只有5%(n = 31)的提供者报告HPV疫苗在推荐当日“总是”被接受。儿科护理机构中的医疗保健提供者和多学科护理团队必须努力找出推荐和接种之间的差距,以最大限度地利用临床机会。针对已确定的障碍进行有效HPV推荐沟通方法和患者教育的培训,可能有助于减少错失的机会并提高HPV疫苗的及时接种率。